Would you like to hear more news stories like this one? If so, head over to LifespanNews for more longevity news, science, and advocacy episodes! Visit [ Ссылка ].
▼▼ Description, sources, and more below ▼▼
In this episode of Lifespan News:
0:00 Intro
0:37 Regenerating Skin With a Single Protein
1:27 A New Senolytic Enters Human Trials
2:27 T Cell Progenitors Boost Stem Cell Therapy Effectiveness
4:24 Creating Anti-Glucosepane Antibodies
5:41 Big pharma enters senolytic drug discovery program
Visit [ Ссылка ] for more of Brent's content!
Executive Producer: Keith Comito
Producer: Nicola Bagalà
Assistant Producer: Sedeer el-Showk
Video Editors: Tim Maupin, Brent Nally
Text Editor: Josh Conway
SOURCES AND FURTHER READING
⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺
Regenerating Skin With a Single Protein:
[ Ссылка ]
[ Ссылка ]
[ Ссылка ]
A New Senolytic Enters Human Trials:
[ Ссылка ]
T Cell Progenitors Boost Stem Cell Therapy Effectiveness:
[ Ссылка ]
Creating Anti-Glucosepane Antibodies:
[ Ссылка ]
Big pharma enters senolytic drug discovery program:
[ Ссылка ]
HOW YOU CAN SUPPORT US
⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺
If you’d like to help us run this show and/or help Lifespan.io end age-related diseases, you can become a Lifespan Hero: [ Ссылка ]. Your support means the world to us!
FOLLOW US EVERYWHERE
⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺
Website: [ Ссылка ]
Instagram: [ Ссылка ]
Facebook: [ Ссылка ]
Twitter: [ Ссылка ]
Discord: [ Ссылка ]
⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺
#Skin #Type2Diabetes #SenescentCells #ClinicalTrials #Cancer #ImmuneSystem #Glucosepane #AI #Insilico
Ещё видео!